Quarterly report [Sections 13 or 15(d)]

Common Stock and Warrants (Details Narrative)

v3.26.1
Common Stock and Warrants (Details Narrative) - USD ($)
 3 Months Ended
Sep. 12, 2025
Mar. 31, 2026
Dec. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Common stock, shares authorized   100,000,000 100,000,000
Common stock, par value   $ 0.001 $ 0.001
Common stock, shares, issued   13,787,000 13,784,000
Common stock, shares, outstanding   13,787,000 13,784,000
Common stock, voting rights   The holders of common stock are entitled to one vote for each share of common stock held.  
Securities Purchase Agreement [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Number of shares sold 2,764,710    
Share per price $ 1.70    
Proceeds from sale of common shares and warrants $ 4,183,000    
Securities Purchase Agreement [Member] | Investor Warrants [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Warrant issued to purchase of common stock 5,529,420    
Warrants exercise price $ 1.50    
Expire date Sep. 27, 2027    
Securities Purchase Agreement [Member] | Placement Agent Warrants [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Warrant issued to purchase of common stock 207,353    
Warrants exercise price $ 2.125    
Fee payment description The Company paid Wainwright consideration consisting of (i) a cash fee equal to 7.0% of the aggregate gross proceeds in the offering, (ii) a management fee equal to 1.0% of the aggregate gross proceeds in the offering, (iii) reimbursement of certain expenses and (iv) warrants to acquire up to an aggregate of 207,353 shares of common stock (the “Placement Agent Warrants”).